Clinical Trials Directory

Trials / Completed

CompletedNCT05008900

Timing of Post-prostatectomy PSMA Imaging

A Phase II Randomized Feasibility Study Comparing Early Salvage Radiotherapy Versus Surveillance With Delayed Repeat PSMA PET/CT Imaging in Patients Presenting With Early Biochemical Relapse of Prostate Cancer Following Radical Prostatectomy

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
4 (actual)
Sponsor
University Health Network, Toronto · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigators will randomize patients presenting with early BCR with a negative baseline PSMA PET/CT, to upfront SRT or surveillance. Early BCR is defined as a PSA relapse of \>0.1 to \<0.3 ng/mL. Patients in the surveillance arm will be monitored with PSA every 3 months. A repeat PSMA PET/CT will be undertaken when the PSA reaches a target level of \>0.5 to \<1.0 ng/mL. Both early radiation treatment and surveillance with repeat PSMA PET/CT imaging are within patterns of practice locally; therefore, the investigators believe that there is clinical equipoise on this subject.

Conditions

Interventions

TypeNameDescription
RADIATIONSalvage radiotherapyStandard of care salvage radiotherapy to the prostate bed which may include the lymph nodes.

Timeline

Start date
2022-03-22
Primary completion
2024-07-08
Completion
2024-07-08
First posted
2021-08-17
Last updated
2026-03-05

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05008900. Inclusion in this directory is not an endorsement.